SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-13-006193
Filing Date
2013-11-12
Accepted
2013-11-12 07:30:39
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0913_soligenix.htm 10-Q 735575
2 CERTIFIATION f10q0913ex31i_soligenix.htm EX-31.1 15436
3 CERTIFIATION f10q0913ex31ii_soligenix.htm EX-31.2 14846
4 CERTIFIATION f10q0913ex32i_soligenix.htm EX-32.1 5691
5 CERTIFIATION f10q0913ex32ii_soligenix.htm EX-32.2 5753
  Complete submission text file 0001213900-13-006193.txt   4567590

Data Files

Seq Description Document Type Size
6 sngx-20130930.xml EX-101.INS 714743
7 sngx-20130930.xsd EX-101.SCH 30742
8 sngx-20130930_cal.xml EX-101.CAL 28033
9 sngx-20130930_def.xml EX-101.DEF 78559
10 sngx-20130930_lab.xml EX-101.LAB 280063
11 sngx-20130930_pre.xml EX-101.PRE 181244
Mailing Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540
Business Address 29 EMMONS DRIVE SUITE C-10 PRINCETON NJ 08540 609-538-8200
SOLIGENIX, INC. (Filer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-16929 | Film No.: 131206961
SIC: 2834 Pharmaceutical Preparations